What it is
CJC-1295 belongs to the growth-hormone axis class, where human studies examine pulsatile GH release, IGF-1 response, lean-mass dynamics, and recovery quality. Pepture treats CJC-1295 purely as a tracking target, meaning the app records what you enter without making any clinical recommendation about whether the compound is right for you. That determination belongs with a licensed clinician who knows your full history.
Most research and practitioner use reports subcutaneous (SubQ) injection with a U-100 insulin syringe. Its half-life of about 8 hours places it in the once-daily to every-other-day dosing window reported in the literature.
The Pepture library entry for CJC-1295 exists so that if you are already logging a CJC-1295 protocol, you can do so with structured fields, cycle calendars, injection-site rotation, and biomarker context rather than a loose notebook. If you are considering starting a protocol with CJC-1295, speak with a licensed clinician before obtaining or dosing the compound.
Common uses
The uses most commonly logged for CJC-1295 in the Pepture community align with its performance positioning. Users track CJC-1295 alongside sleep depth, fasted weight, IGF-1 when available, and strength output, so the protocol's impact can be evaluated over a full cycle rather than by memory.
Typical logged doses in Pepture sit in the 100 mcg to 200 mcg range; individual protocols vary substantially.
Pepture makes no claim about efficacy. CJC-1295 is either FDA-approved, used under a prescription, or labelled for research only depending on the jurisdiction. Confirm the legal and clinical status of CJC-1295 in your country with a licensed clinician before use.
Reconstitution math
Open the pre-filled CJC-1295 reconstitution calculator to compute syringe units per dose.
Reconstitution guidance
Typical vial size 5 mg. Reconstitute with 2 mL bacteriostatic water. Refrigerate after reconstitution per manufacturer or clinician guidance. Standard storage window: 28d refrigerated.
Stack combinations
Often paired with complementary GH-axis peptides in performance stacks. Pepture flags overlapping half-lives.
Cycle length norms
Tracked users commonly run 84 on / 28 off. Cycle norms vary by individual and by clinician guidance. Pepture lets you configure any on/off window that matches your protocol.
Safety considerations
Every peptide carries context-specific risks. Work with a licensed clinician who knows your medical history before starting or adjusting a protocol. Stop and seek medical attention for severe injection site reactions, unexpected swelling, shortness of breath, persistent elevated heart rate, rash, or any reaction you did not anticipate. Pepture does not assess efficacy or safety for any individual.
Reported Side Effects of CJC-1295
Effects below are summarised from peer-reviewed literature or regulatory labeling where it exists. Not medical advice. Individual responses vary.
- Water retention and mild peripheral edema Endocrine Reviews
- Joint discomfort and carpal-tunnel-type symptoms at higher doses J Clin Endocrinol Metab
- Transient rise in fasting glucose and HbA1c in sensitive users J Clin Endocrinol Metab
- Increased appetite (orally-active secretagogues) PubMed
- Injection-site redness or itching (injected secretagogues) PubMed
Used in these Pepture routines
CJC-1295 appears in the following Pepture stack templates. Tap to load the full routine.
Compare CJC-1295
How CJC-1295 stacks up against the peers most users consider.
References
For peer-reviewed literature, search PubMed for CJC-1295. Pepture does not link to vendor or retail sites.
Disclaimer
The information on this page is for informational purposes only and is not medical, legal, or regulatory advice. Pepture does not sell, supply, prescribe, or recommend any peptide. Many peptides are investigational or restricted in specific jurisdictions.